This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 49/5/1077    most recent HYPERTENSIONAHA.107.087320v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muiesan, M. L. Articles by Agabiti Rosei, E. Search for Related Content PubMed PubMed Citation Articles by Muiesan, M. L. Articles by Agabiti Rosei, E. Related Collections Other hypertension Hypertrophy Echocardiography

(Hypertension. 2007;49:1077.)
© 2007 American Heart Association, Inc.

Original Articles

Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients

Maria Lorenza Muiesan; Massimo Salvetti; Anna Paini; Cristina Monteduro; Gloria Galbassini; Bianca Bonzi; Paolo Poisa; Eugenia Belotti; Claudia Agabiti Rosei; Damiano Rizzoni; Maurizio Castellano; Enrico Agabiti Rosei

From the Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy.

Correspondence to Maria Lorenza Muiesan, Department of Medical and Surgical Sciences, University of Brescia, 25100 Brescia, Italy. E-mail muiesan{at}med.unibs.it

Inappropriate left ventricular mass (LVM; ie, the value of LVM exceeding individual needs to compensate hemodynamic load) predicts the risk of cardiovascular (CV) events, independent of risk factors, either in the presence or in the absence of traditionally defined LV hypertrophy. The relation between changes in appropriateness of LVM during antihypertensive treatment and subsequent prognosis was evaluated in 436 prospectively identified uncomplicated hypertensive subjects, with a baseline and follow-up standard clinical evaluation, laboratory examinations, and echocardiogram (last examination: 6±3 years apart), followed for additional 4.5±2.5 years. The appropriateness of LVM to cardiac workload was calculated by the ratio of observed LVM to the value predicted for individual sex, height, and stroke work at rest. At baseline, low or appropriate LVM (128% of predicted) was found in 178 patients, and 258 had inappropriate LVM. A first CV event occurred in 82 patients. Event rate (x100 patient-years) was 3.18 among patients with inappropriate LVM persistence (n=152), 0.97 among patients with inappropriate LVM regression (n=104), 1.87 among patients with inappropriate LVM development (n=75), and 0.81 among patients with persistence of appropriate LVM from baseline to the follow-up (n=105; log-rank test: P=0.0001). Cox’s proportional hazard model, considering all of the known CV risk factors, indicated that age, male sex, persistence, or development of inappropriate LVM, in addition to persistence and development of LVH, were independently associated with the occurrence of CV events (P<0.001). The presence of inappropriate LVM during antihypertensive treatment may adversely influence subsequent CV prognosis.

Key Words: hypertension • hypertrophy left ventricular • echocardiography • prognosis • cardiovascular disease

This article has been cited by other articles:

				A. Scuteri, R. Coluccia, L. Castello, E. Nevola, A. M. Brancati, and M. Volpe Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure Eur. Heart J., June 2, 2009; 30(12): 1525 - 1529. [Abstract] [Full Text] [PDF]

				J Y S Chan, A M Li, C-T Au, A F C Lo, S-K Ng, V J Abdullah, C Ho, C-M Yu, T-F Fok, and Y-K Wing Cardiac remodelling and dysfunction in children with obstructive sleep apnoea: a community based study Thorax, March 1, 2009; 64(3): 233 - 239. [Abstract] [Full Text] [PDF]

				M. L. Muiesan, M. Salvetti, A. Paini, C. Agabiti-Rosei, C. Monteduro, G. Galbassini, E. Belotti, C. Aggiusti, D. Rizzoni, M. Castellano, et al. Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism Hypertension, September 1, 2008; 52(3): 529 - 534. [Abstract] [Full Text] [PDF]

				J. Diez Effects of Aldosterone on the Heart: Beyond Systemic Hemodynamics? Hypertension, September 1, 2008; 52(3): 462 - 464. [Full Text] [PDF]

				G. Grassi, F. Quarti-Trevano, and G. Mancia Review: Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 66 - 74. [Abstract] [PDF]

				E. Agabiti-Rosei, M. L. Muiesan, and M. Salvetti Review: New approaches to the assessment of left ventricular hypertrophy Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 119 - 128. [Abstract] [PDF]

				B. Lopez, J. M. Castellano, A. Gonzalez, J. Barba, and J. Diez Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension Hypertension, November 1, 2007; 50(5): 977 - 983. [Abstract] [Full Text] [PDF]